Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm
- PMID: 20454838
- DOI: 10.1007/s11095-010-0164-0
Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm
Abstract
Purpose: Matrix metalloproteinases (MMP) are a family of proteolytic enzymes, the expression of which in a key step of tumor progression has been better defined recently. The studies highlighted the ongoing need for very specific inhibitors, substrates or release devices designed to be selective for one or at least very few MMPs.
Methods: This report deals with the design, synthesis and in vitro evaluation of linear and especially novel cyclic peptidic moieties, embodying MMP cleavable sequences designed to answer these questions. FRET (fluorescence resonance energy transfer) labelling via chromophore-modified amino-acids was used to give access to enzyme kinetics.
Results: Evaluation of these peptides showed that cyclisation gives rise to high specificity for certain MMP, suggesting that this approach could provide very specific MMP substrate. Moreover, cyclic structures present a very good plasma stability.
Conclusions: These original derivatives could allow the design of MMP-controlled delivery devices, the specificity of which will be retained in complex biological media and in vivo.
Similar articles
-
Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation.Int J Nanomedicine. 2016 Apr 22;11:1643-61. doi: 10.2147/IJN.S101030. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27217744 Free PMC article.
-
Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.Curr Top Med Chem. 2020;20(27):2459-2471. doi: 10.2174/1568026620666200722104928. Curr Top Med Chem. 2020. PMID: 32703131 Review.
-
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.Arch Biochem Biophys. 2003 Jan 15;409(2):335-40. doi: 10.1016/s0003-9861(02)00612-4. Arch Biochem Biophys. 2003. PMID: 12504900
-
Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.Methods Mol Biol. 2016;1406:161-70. doi: 10.1007/978-1-4939-3444-7_13. Methods Mol Biol. 2016. PMID: 26820953
-
Matrix metalloprotease inhibitors: design from structure.Biochem Soc Trans. 2004 Feb;32(Pt 1):17-20. doi: 10.1042/bst0320017. Biochem Soc Trans. 2004. PMID: 14748704 Review.
Cited by
-
HPMA Copolymers: A Versatile Platform for Targeted Peptide Drug Delivery.Biomolecules. 2025 Apr 17;15(4):596. doi: 10.3390/biom15040596. Biomolecules. 2025. PMID: 40305357 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources